Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02219789 |
Title | Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery |
Recruitment | Completed |
Gender | female |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Mayo Clinic |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |